XML 29 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1

Revenues (Tables)

6 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2018 and 2017:

			Three months ended June 30,																		Six months ended June 30,
			2018						2017						2018						2017
Products:
Acetadote			$	841,431					$	1,723,984					$	2,115,741					$	2,989,424
Omeclamox-Pak			89,952						377,470						231,344						1,022,795
Kristalose			3,203,743						2,901,440						6,473,097						5,288,031
Vaprisol			1,685,900						276,705						1,779,790						961,253
Caldolor			1,101,023						1,052,917						2,140,771						1,865,944
Ethyol			2,809,691						2,091,836						5,065,764						5,758,644
Totect			269,190						—						681,964						—
Other			162,794						242,775						262,858						417,791
Total net revenues			$	10,163,724					$	8,667,127					$	18,751,329					$	18,303,882

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration